Answers are grounded in this paper and cite their sources.
To the Editors: Pravastatin sodium is a 3-hydroxyl-3-methylglutaryl-CoA reductase blocker used in the treatment of hypercholesterolaemia. We report on a patient who developed bilateral pleural effusions while he was being treated with the drug. The patient was a 60-yr-old male, a nonsmoker who was under treatment with 40 mg·day−1 pravastatin since September 2005. He had no history of allergy or significant environmental or occupational exposure to agents that may harm the respiratory system. He presented with persistent bilateral pleuritic chest pain and mild dyspnoea of several days’ duration in September 2006. He had neither constitutional symptoms nor extrathoracic abnormalities. A chest radiograph revealed small bilateral pleural effusions …
No takes yet. Share an insight, caveat, or question.
Kalomenidis et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: